Acrivon Therapeutics, Inc. — 3 Filings
20 3 filings on record
This page lists all 3 filings submitted to the SEC by Acrivon Therapeutics, Inc. (ACRV), sorted by most recent first. Each row links to the full filing on EdgarLookup. Acrivon Therapeutics, Inc. has filed 20 3 documents with the SEC since 2021. To view all SEC filings by Acrivon Therapeutics, Inc., see the full filings list.
All
10-K
10-Q
144
3
3/A
4
424B4
8-A12B
8-K
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DEFR14A
DRS
DRS/A
DRSLTR
EFFECT
FWP
S-1
S-1/A
S-1MEF
S-3
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 3 | — | 0000905148-25-001264 | Apr 21, 2025 | Apr 9, 2025 |
| 3 | — | 0000905148-25-001074 | Apr 3, 2025 | Apr 1, 2025 |
| 3 | — | 0000905148-24-001481 | May 16, 2024 | May 13, 2024 |
| 3 | — | 0000905148-24-000901 | Mar 6, 2024 | Mar 4, 2024 |
| 3 | — | 0000905148-24-000531 | Feb 9, 2024 | Feb 8, 2024 |
| 3 | — | 0000905148-24-000165 | Jan 12, 2024 | Jan 2, 2024 |
| 3 | — | 0000905148-23-001028 | Sep 28, 2023 | Sep 26, 2023 |
| 3 | — | 0001140361-23-031954 | Jun 28, 2023 | Jun 22, 2023 |
| 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-22-022492 | Nov 18, 2022 | Nov 17, 2022 |
| 3 | — | 0001213900-22-070760 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0000899243-22-035474 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056309 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056308 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056307 | Nov 9, 2022 | — |
| 3 | OWNERSHIP DOCUMENT | 0001104659-22-116650 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056306 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056305 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056304 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056303 | Nov 9, 2022 | — |
| 3 | FORM 3 SUBMISSION | 0001209191-22-056302 | Nov 9, 2022 | — |